{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T03:21:55Z","timestamp":1794626515217,"version":"4.9.1"},"reference-count":298,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.pharmthera.2024.108753","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T07:43:09Z","timestamp":1731915789000},"page":"108753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Pro-resolving lipid mediators and therapeutic innovations in resolution of inflammation"],"prefix":"10.1016","volume":"265","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6098-9381","authenticated-orcid":false,"given":"Hong Yong","family":"Peh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2024.108753_bb0005","doi-asserted-by":"crossref","first-page":"16526","DOI":"10.1073\/pnas.1407123111","article-title":"Maresin 1 biosynthesis during platelet\u2013neutrophil interactions is organ-protective","volume":"111","author":"Abdulnour","year":"2014","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"23","key":"10.1016\/j.pharmthera.2024.108753_bb0010","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1111\/bph.17322","article-title":"Effects of a pro-resolving drug in COVID-19: Preclinical studies to a randomized, placebo-controlled, phase Ib\/IIa trial in hospitalized patients","volume":"181","author":"Almeida","year":"2024","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0015","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1182\/blood-2023-188727","article-title":"A phase 2, open-label study to assess the pharmacokinetics, pharmacodynamics and safety of orally administered Epeleuton in patients with sickle cell disease","volume":"142","author":"Andemariam","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0020","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.20042031","article-title":"Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1","volume":"201","author":"Arita","year":"2005","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbrc.2005.07.181","article-title":"The contributions of aspirin and microbial oxygenase to the biosynthesis of anti-inflammatory resolvins: Novel oxygenase products from \u03c9-3 polyunsaturated fatty acids","volume":"338","author":"Arita","year":"2005","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0030","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.4049\/jimmunol.178.6.3912","article-title":"Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate Inflammation1","volume":"178","author":"Arita","year":"2007","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0035","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.4049\/jimmunol.1502268","article-title":"Resolvin D3 is dysregulated in arthritis and reduces arthritic inflammation","volume":"197","author":"Arnardottir","year":"2016","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0040","doi-asserted-by":"crossref","first-page":"9003","DOI":"10.1021\/acs.jmedchem.9b02101","article-title":"Discovery of BMS-986235\/LAR-1219: A potent formyl peptide receptor 2 (FPR2) selective agonist for the prevention of heart failure","volume":"63","author":"Asahina","year":"2020","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0045","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jaci.2006.04.031","article-title":"Abrogation of allergic reactions by a bispecific antibody fragment linking IgE to CD300a","volume":"117","author":"Bachelet","year":"2006","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0050","doi-asserted-by":"crossref","first-page":"7989","DOI":"10.4049\/jimmunol.175.12.7989","article-title":"The inhibitory receptor IRp60 (CD300a) is expressed and functional on human mast Cells1","volume":"175","author":"Bachelet","year":"2005","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0055","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-21940-8","article-title":"Activation of GPR37 in macrophages confers protection against infection-induced sepsis and pain-like behaviour in mice","volume":"12","author":"Bang","year":"2021","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0060","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1172\/JCI99888","article-title":"GPR37 regulates macrophage phagocytosis and resolution of inflammatory pain","volume":"128","author":"Bang","year":"2018","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0065","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/sj.bjp.0705912","article-title":"Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration","volume":"143","author":"Bannenberg","year":"2004","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0070","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.4049\/jimmunol.174.7.4345","article-title":"Molecular circuits of resolution: Formation and actions of Resolvins and Protectins1","volume":"174","author":"Bannenberg","year":"2005","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0075","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004812","article-title":"Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma","volume":"5","author":"Barnig","year":"2013","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0080","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1166\/jbn.2015.2024","article-title":"Local administration of gold nanoparticles prevents pivotal pathological changes in murine models of atopic asthma","volume":"11","author":"Barreto","year":"2015","journal-title":"Journal of Biomedical Nanotechnology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01596","article-title":"Angiotensin-(1-7) promotes resolution of neutrophilic inflammation in a model of antigen-induced arthritis in mice","volume":"8","author":"Barroso","year":"2017","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0090","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.expneurol.2012.04.007","article-title":"Novel aspirin-triggered neuroprotectin D1 attenuates cerebral ischemic injury after experimental stroke","volume":"236","author":"Bazan","year":"2012","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0095","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jocn.2019.03.032","article-title":"Brain tissue saving effects by single-dose intralesional administration of Neuroprotectin D1 on experimental focal penetrating brain injury in rats","volume":"64","author":"Berg","year":"2019","journal-title":"Journal of Clinical Neuroscience"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0100","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/CIRCULATIONAHA.106.629907","article-title":"Augmentation of myocardial production of 15-epi-lipoxin-A4 by pioglitazone and atorvastatin in the rat","volume":"114","author":"Birnbaum","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0105","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.2353\/ajpath.2006.051056","article-title":"Lipoxin A4 regulates bronchial epithelial cell responses to acid injury","volume":"168","author":"Bonnans","year":"2006","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0110","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1164\/rccm.200201-053OC","article-title":"Lipoxins are potential endogenous Antiinflammatory mediators in asthma","volume":"165","author":"Bonnans","year":"2002","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0115","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1096\/fj.11-185017","article-title":"Lipoxin A4 and benzo-lipoxin A4 attenuate experimental renal fibrosis","volume":"25","author":"B\u00f6rgeson","year":"2011","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0120","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cmet.2015.05.003","article-title":"Lipoxin A4 attenuates obesity-induced adipose inflammation and associated liver and kidney disease","volume":"22","author":"B\u00f6rgeson","year":"2015","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0125","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.euroneuro.2015.12.031","article-title":"Effects of omega-3 polyunsaturated fatty acids on human brain morphology and function: What is the evidence?","volume":"26","author":"Bos","year":"2016","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0130","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2017101112","article-title":"Lipoxins regulate the early growth response\u20131 network and reverse diabetic kidney disease","volume":"29","author":"Brennan","year":"2018","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0135","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2313089121","article-title":"Specialized proresolving mediator resolvin E1 corrects the altered cystic fibrosis nasal epithelium cilia beating dynamics","volume":"121","author":"Briottet","year":"2024","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0140","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMra2032506","article-title":"Biologic therapies for severe asthma","volume":"386","author":"Brusselle","year":"2022","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0145","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1016\/j.bmcl.2006.04.068","article-title":"Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents","volume":"16","author":"B\u00fcrli","year":"2006","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0150","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1194\/jlr.D500042-JLR200","article-title":"A one-step method of 10,17-dihydro(pero)xydocosahexa-4Z,7Z,11E,13Z,15E,19Z-enoic acid synthesis by soybean lipoxygenase","volume":"47","author":"Butovich","year":"2006","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0155","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.biochi.2020.08.015","article-title":"Eicosapentaenoic and docosahexaenoic acid derived specialised pro-resolving mediators: Concentrations in humans and the effects of age, sex, disease and increased omega-3 fatty acid intake","volume":"178","author":"Calder","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0160","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1038\/sj.ejcn.1601478","article-title":"Polyunsaturated fatty acids, inflammation and immunity","volume":"56","author":"Calder","year":"2002","journal-title":"European Journal of Clinical Nutrition"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0165","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1084\/jem.20071601","article-title":"Synthetic chemerin-derived peptides suppress inflammation through ChemR23","volume":"205","author":"Cash","year":"2008","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0170","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/life11030243","article-title":"Regulation of inflammation and oxidative stress by formyl peptide receptors in cardiovascular disease progression","volume":"11","author":"Caso","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0175","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020385118","article-title":"Annexin A1 attenuates cardiac diastolic dysfunction in mice with inflammatory arthritis","volume":"118","author":"Chen","year":"2021","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.107005","article-title":"The Annexin-A1 mimetic RTP-026 promotes acute cardioprotection through modulation of immune cell activation","volume":"198","author":"Chen","year":"2023","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.02080","article-title":"RvE1 attenuates Polymicrobial Sepsis-induced cardiac dysfunction and enhances bacterial clearance","volume":"11","author":"Chen","year":"2020","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0190","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1016\/j.febslet.2009.10.004","article-title":"Full characterization of PDX, a neuroprotectin\/protectin D1 isomer, which inhibits blood platelet aggregation","volume":"583","author":"Chen","year":"2009","journal-title":"FEBS Letters"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0195","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1096\/fj.10-161836","article-title":"Poxytrins, a class of oxygenated products from polyunsaturated fatty acids, potently inhibit blood platelet aggregation","volume":"25","author":"Chen","year":"2011","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0200","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1182\/blood.2018886317","article-title":"Resolvin D4 attenuates the severity of pathological thrombosis in mice","volume":"134","author":"Cherpokova","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0205","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.20150225","article-title":"Identification of resolvin D2 receptor mediating resolution of infections and organ protection","volume":"212","author":"Chiang","year":"2015","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0210","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature11042","article-title":"Infection regulates pro-resolving mediators that lower antibiotic requirements","volume":"484","author":"Chiang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0215","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1172\/JCI7016","article-title":"Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion","volume":"104","author":"Chiang","year":"1999","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0220","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1172\/JCI129448","article-title":"Maresin 1 activates LGR6 receptor promoting phagocyte immunoresolvent functions","volume":"129","author":"Chiang","year":"2023","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0225","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/EBC20200018","article-title":"Specialized pro-resolving mediator network: An update on production and actions","volume":"64","author":"Chiang","year":"2020","journal-title":"Essays in Biochemistry"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0230","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/sj.bjp.0705220","article-title":"A novel rat lipoxin A 4 receptor that is conserved in structure and function","volume":"139","author":"Chiang","year":"2003","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0235","first-page":"779","article-title":"Aspirin-triggered 15-epi-Lipoxin A<sub>4<\/sub> (ATL) generation by human leukocytes and murine peritonitis exudates: Development of a specific 15-epi-LXA<sub>4<\/sub> ELISA","volume":"287","author":"Chiang","year":"1998","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0240","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1021\/jm900592h","article-title":"6-Methyl-2,4-Disubstituted Pyridazin-3(2H)-ones: A novel class of small-molecule agonists for formyl peptide receptors","volume":"52","author":"Cilibrizzi","year":"2009","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0245","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/BF03401642","article-title":"Aspirin-triggered Lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)\u2013neutrophil interactions and are potent inhibitors of cell proliferation","volume":"2","author":"Cl\u00e0ria","year":"1996","journal-title":"Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0250","doi-asserted-by":"crossref","first-page":"9475","DOI":"10.1073\/pnas.92.21.9475","article-title":"Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions","volume":"92","author":"Cl\u00e0ria","year":"1995","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0255","doi-asserted-by":"crossref","first-page":"25372","DOI":"10.1074\/jbc.M002863200","article-title":"Oxidoreductases in Lipoxin A4 metabolic inactivation: A novel role for 15-oxoprostaglandin 13-reductase\/leukotriene B4 12-hydroxydehydrogenase in inflammation","volume":"275","author":"Clish","year":"2000","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0260","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nm1591","article-title":"Increased dietary intake of \u03c9-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis","volume":"13","author":"Connor","year":"2007","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0265","doi-asserted-by":"crossref","first-page":"18232","DOI":"10.1073\/pnas.1308253110","article-title":"Ligand-specific conformational change of the G-protein\u2013coupled receptor ALX\/FPR2 determines proresolving functional responses","volume":"110","author":"Cooray","year":"2013","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0270","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1681\/ASN.2016101066","article-title":"Immunologic effects of the renin-angiotensin system","volume":"28","author":"Crowley","year":"2017","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0275","doi-asserted-by":"crossref","first-page":"6478","DOI":"10.4049\/jimmunol.1203000","article-title":"Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2\/lipoxin A4 receptor","volume":"190","author":"Dalli","year":"2013","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149319","article-title":"Identification and actions of a novel third Maresin conjugate in tissue regeneration: MCTR3","volume":"11","author":"Dalli","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0285","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1182\/blood-2012-04-423525","article-title":"Specific lipid mediator signatures of human phagocytes: Microparticles stimulate macrophage efferocytosis and pro-resolving mediators","volume":"120","author":"Dalli","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0290","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.chembiol.2012.11.010","article-title":"Resolvin D3 and aspirin-triggered Resolvin D3 are potent Immunoresolvents","volume":"20","author":"Dalli","year":"2013","journal-title":"Chemistry & Biology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0295","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1096\/fj.13-227728","article-title":"The novel 13S,14S -epoxy-maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype","volume":"27","author":"Dalli","year":"2013","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0300","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1096\/fj.99-0602fje","article-title":"Lipocortin 1 reduces myocardial ischemia-reperfusion injury by affecting local leukocyte recruitment","volume":"14","author":"D\u2019Amico","year":"2000","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0305","article-title":"Maresin biosynthesis and identification of Maresin 2, a new anti-inflammatory and pro-resolving mediator from human macrophages","volume":"9","author":"Deng","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0310","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jphs.2018.09.006","article-title":"Resolvin E3 attenuates lipopolysaccharide-induced depression-like behavior in mice","volume":"138","author":"Deyama","year":"2018","journal-title":"Journal of Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0315","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00213-017-4774-7","article-title":"Resolvin E1\/E2 ameliorate lipopolysaccharide-induced depression-like behaviors via ChemR23","volume":"235","author":"Deyama","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0320","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12951-021-00796-6","article-title":"Gold nanoparticles reduce inflammation in cerebral microvessels of mice with sepsis","volume":"19","author":"Di Bella","year":"2021","journal-title":"Journal of Nanobiotechnology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0325","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00464-17","article-title":"Specialized Proresolving mediators rescue infant mice from lethal Citrobacter rodentium infection and promote immunity against reinfection","volume":"85","author":"Diaz","year":"2017","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0330","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s10571-022-01216-5","article-title":"Cerebrospinal fluid profile of lipid mediators in Alzheimer\u2019s disease","volume":"43","author":"Do","year":"2023","journal-title":"Cellular and Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0335","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/cmdc.200900533","article-title":"Synthesis and biological evaluation of pyridine-containing Lipoxin A4 analogues","volume":"5","author":"Duffy","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0340","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aam5446","article-title":"Natural killer cell\u2013mediated inflammation resolution is disabled in severe asthma","volume":"2","author":"Duvall","year":"2017","journal-title":"Science Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0345","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0006-291X(88)80320-6","article-title":"Transcellular conversion of endogenous arachidonic acid to lipoxins in mixed human platelet-granulocyte suspensions","volume":"157","author":"Edenius","year":"1988","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0350","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1161\/HYPERTENSIONAHA.120.16237","article-title":"FPR-1 (formyl peptide Receptor-1) activation promotes spontaneous, premature hypertension in dahl salt-sensitive rats","volume":"77","author":"Edwards","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0355","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.3390\/nu12072090","article-title":"Perinatal docosahexaenoic acid supplementation improves cognition and alters brain functional Organization in Piglets","volume":"12","author":"Fang","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0360","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1111\/bph.14647","article-title":"The specialised pro-resolving lipid mediator maresin 1 reduces inflammatory pain with a long-lasting analgesic effect","volume":"176","author":"Fattori","year":"2019","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109189","article-title":"Maresin 2 is an analgesic specialized pro-resolution lipid mediator in mice by inhibiting neutrophil and monocyte recruitment, nociceptor neuron TRPV1 and TRPA1 activation, and CGRP release","volume":"216","author":"Fattori","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0370","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1073\/pnas.0710127105","article-title":"Eoxins are proinflammatory arachidonic acid metabolites produced via the 15-lipoxygenase-1 pathway in human eosinophils and mast cells","volume":"105","author":"Feltenmark","year":"2008","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0375","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1016\/j.jacc.2019.03.503","article-title":"Pro-Angiogenic macrophage phenotype to promote myocardial repair","volume":"73","author":"Ferraro","year":"2019","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0380","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1084\/jem.180.1.253","article-title":"Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor","volume":"180","author":"Fiore","year":"1994","journal-title":"Journal of Experimental Medicine"},{"issue":"11","key":"10.1016\/j.pharmthera.2024.108753_bb0385","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s41569-023-00984-x","article-title":"Specialized pro-resolving mediators in vascular inflammation and atherosclerotic cardiovascular disease","volume":"21","author":"Fredman","year":"2024","journal-title":"Nature Reviews. Cardiology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0390","doi-asserted-by":"crossref","first-page":"718","DOI":"10.4049\/jimmunol.1601543","article-title":"Neutrophil Resolvin E1 receptor expression and function in type 2 diabetes","volume":"198","author":"Freire","year":"2017","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0395","doi-asserted-by":"crossref","first-page":"14190","DOI":"10.1021\/acs.joc.0c01701","article-title":"Synthesis of Resolvin E3, a Proresolving lipid mediator, and its deoxy derivatives: Identification of 18-deoxy-resolvin E3 as a potent anti-inflammatory agent","volume":"85","author":"Fukuda","year":"2020","journal-title":"The Journal of Organic Chemistry"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0400","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.4049\/jimmunol.174.8.5033","article-title":"Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung Injury1","volume":"174","author":"Fukunaga","year":"2005","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0405","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejmech.2018.10.049","article-title":"Asymmetric synthesis and biological evaluation of imidazole- and oxazole-containing synthetic lipoxin A4 mimetics (sLXms)","volume":"162","author":"de Gaetano","year":"2019","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0410","doi-asserted-by":"crossref","first-page":"9193","DOI":"10.1021\/acs.jmedchem.1c00403","article-title":"Asymmetric synthesis and biological screening of Quinoxaline-containing synthetic Lipoxin A4 mimetics (QNX-sLXms)","volume":"64","author":"de Gaetano","year":"2021","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0415","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.jaci.2015.11.045","article-title":"Airway lipoxin A4\/formyl peptide receptor 2\u2013lipoxin receptor levels in pediatric patients with severe asthma","volume":"137","author":"Gagliardo","year":"2016","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105445","article-title":"Therapeutic potential of the FPR2\/ALX agonist AT-01-KG in the resolution of articular inflammation","volume":"165","author":"Galv\u00e3o","year":"2021","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0425","series-title":"Advances in pharmacology","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/bs.apha.2023.02.002","article-title":"Chapter five - targeting the renin angiotensin system for respiratory diseases","volume":"Vol. 98","author":"Gan","year":"2023"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0430","first-page":"676","article-title":"Selective FPR2 Agonism promotes a Proresolution macrophage phenotype and improves cardiac structure-function post myocardial infarction","volume":"6","author":"Garc\u00eda","year":"2021","journal-title":"JACC: Basic to Translational Science"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0435","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41418-019-0370-1","article-title":"Resolvin D1 promotes the targeting and clearance of necroptotic cells","volume":"27","author":"Gerlach","year":"2020","journal-title":"Cell Death and Differentiation"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0440","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41590-019-0356-7","article-title":"Dynamic changes to lipid mediators support transitions among macrophage subtypes during muscle regeneration","volume":"20","author":"Giannakis","year":"2019","journal-title":"Nature Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0445","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.3324\/haematol.2019.219519","article-title":"Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction","volume":"105","author":"Gijs","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0450","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1073\/pnas.1804000116","article-title":"Aspirin-triggered proresolving mediators stimulate resolution in cancer","volume":"116","author":"Gilligan","year":"2019","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0455","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3109\/17435390.2010.516026","article-title":"Biodistribution and acute toxicity of naked gold nanoparticles in a rabbit hepatic tumor model","volume":"5","author":"Glazer","year":"2011","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0460","doi-asserted-by":"crossref","first-page":"18685","DOI":"10.1073\/pnas.1410938111","article-title":"Nonredundant protective properties of FPR2\/ALX in polymicrobial murine sepsis","volume":"111","author":"Gobbetti","year":"2014","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0465","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev-pharmtox-051921-085407","article-title":"Lipoxin mimetics and the resolution of inflammation","volume":"63","author":"Godson","year":"2023","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0470","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.4049\/jimmunol.164.4.1663","article-title":"Cutting edge: Lipoxins rapidly stimulate Nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived Macrophages1","volume":"164","author":"Godson","year":"2000","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0475","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1096\/fj.08-125674","article-title":"Obesity-induced insulin resistance and hepatic steatosis are alleviated by \u03c9-3 fatty acids: A role for resolvins and protectins","volume":"23","author":"Gonz\u00e1lez-P\u00e9riz","year":"2009","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0480","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0002-9440(10)63937-5","article-title":"Selectivity of recombinant human leukotriene D4, leukotriene B4, and Lipoxin A4 receptors with aspirin-triggered 15-epi-LXA4 and regulation of vascular and inflammatory responses","volume":"158","author":"Gronert","year":"2001","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0485","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.704163","article-title":"Safety and preliminary efficacy of a novel host-modulatory therapy for reducing gingival inflammation","volume":"12","author":"Hasturk","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0490","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.4049\/jimmunol.1004007","article-title":"NK cells are effectors for Resolvin E1 in the timely resolution of allergic airway inflammation","volume":"186","author":"Haworth","year":"2011","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0495","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.jid.2018.03.1498","article-title":"Biosynthesis of D-series Resolvins in skin provides insights into their role in tissue repair","volume":"138","author":"Hellmann","year":"2018","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0500","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/ni1205-1179","article-title":"Dampening inflammation","volume":"6","author":"Henson","year":"2005","journal-title":"Nature Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0505","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.2353\/ajpath.2010.091082","article-title":"Aspirin-triggered Lipoxin and Resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis","volume":"177","author":"Ho","year":"2010","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0510","doi-asserted-by":"crossref","first-page":"15025","DOI":"10.1038\/nrdp.2015.25","article-title":"Asthma","volume":"1","author":"Holgate","year":"2015","journal-title":"Nature Reviews. Disease Primers"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0515","doi-asserted-by":"crossref","first-page":"14677","DOI":"10.1074\/jbc.M300218200","article-title":"Novel Docosatrienes and 17S-Resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells: AUTACOIDS IN ANTI-INFLAMMATION*","volume":"278","author":"Hong","year":"2003","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0520","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.3390\/molecules29061258","article-title":"Uncovering the power of GPR18 Signalling: How RvD2 and other ligands could have the potential to modulate and resolve inflammation in various health disorders","volume":"29","author":"Honkisz-Orzechowska","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0525","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.4049\/jimmunol.2100766","article-title":"Atopic neutrophils prevent Postviral airway disease","volume":"207","author":"Hussain","year":"2021","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0530","doi-asserted-by":"crossref","first-page":"5823","DOI":"10.3390\/molecules26195823","article-title":"Synthesis, chemical\u2013physical characterization, and biomedical applications of functional gold nanoparticles: a review","volume":"26","author":"Ielo","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0535","first-page":"423","article-title":"Resolvin D2 limits secondary tissue necrosis after burn wounds in rats","volume":"39","author":"Inoue","year":"2018","journal-title":"Journal of Burn Care & Research"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0540","doi-asserted-by":"crossref","first-page":"10525","DOI":"10.1074\/jbc.M112.340612","article-title":"Identification and structure determination of novel anti-inflammatory mediator Resolvin E3, 17,18-Dihydroxyeicosapentaenoic acid*","volume":"287","author":"Isobe","year":"2012","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0545","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/s41431-022-01108-8","article-title":"A comprehensive SARS-CoV-2 and COVID-19 review, Part 1: Intracellular overdrive for SARS-CoV-2 infection","volume":"30","author":"Jamison","year":"2022","journal-title":"European Journal of Human Genetics"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0550","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev-pharmtox-051921-084047","article-title":"Specialized pro-resolving mediators as resolution pharmacology for the control of pain and itch","volume":"63","author":"Ji","year":"2023","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0555","doi-asserted-by":"crossref","first-page":"13794","DOI":"10.1096\/fj.201902003R","article-title":"Biosynthetic metabolomes of cysteinyl-containing immunoresolvents","volume":"33","author":"Jouvene","year":"2019","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0560","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1002\/jcp.27165","article-title":"Immune responsive resolvin D1 programs peritoneal macrophages and cardiac fibroblast phenotypes in diversified metabolic microenvironment","volume":"234","author":"Kain","year":"2019","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0565","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.expneurol.2017.11.005","article-title":"Combined administration of resolvin E1 and lipoxin A4 resolves inflammation in a murine model of Alzheimer\u2019s disease","volume":"300","author":"Kantarci","year":"2018","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0570","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40478-024-01767-2","article-title":"Dysregulation of neuroprotective lipoxin pathway in astrocytes in response to cytokines and ocular hypertension","volume":"12","author":"Karnam","year":"2024","journal-title":"Acta Neuropathologica Communications"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0575","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/mi.2014.116","article-title":"Lipoxin B4 promotes the resolution of allergic inflammation in the upper and lower airways of mice","volume":"8","author":"Karra","year":"2015","journal-title":"Mucosal Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0580","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.4049\/jimmunol.1801000","article-title":"Leukocyte CD300a contributes to the resolution of murine allergic inflammation","volume":"201","author":"Karra","year":"2018","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0585","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jaci.2013.01.058","article-title":"Exhaled breath condensate eicosanoid levels associate with asthma and its severity","volume":"132","author":"Kazani","year":"2013","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0590","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s10787-007-0021-x","article-title":"Clinical pharmacology of gold","volume":"16","author":"Kean","year":"2008","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0595","doi-asserted-by":"crossref","first-page":"H153","DOI":"10.1152\/ajpheart.01057.2009","article-title":"Resolvin E1 protects the rat heart against reperfusion injury","volume":"299","author":"Keyes","year":"2010","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0600","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150861","article-title":"Anti-inflammatory action of angiotensin 1-7 in experimental colitis","volume":"11","author":"Khajah","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0605","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.4049\/jimmunol.1700503","article-title":"Lipoxin B4 enhances human memory B cell antibody production via upregulating Cyclooxygenase-2 expression","volume":"201","author":"Kim","year":"2018","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0610","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1038\/s41467-019-11928-w","article-title":"Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson\u2019s disease","volume":"10","author":"Krashia","year":"2019","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0615","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1152\/physrev.00026.2017","article-title":"Specialized Proresolving mediators in innate and adaptive immune responses in airway diseases","volume":"98","author":"Krishnamoorthy","year":"2018","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0620","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2206480120","article-title":"The Maresin 1\u2013LGR6 axis decreases respiratory syncytial virus-induced lung inflammation","volume":"120","author":"Krishnamoorthy","year":"2023","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0625","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.ajpath.2012.01.028","article-title":"Resolvin D1 receptor Stereoselectivity and regulation of inflammation and Proresolving MicroRNAs","volume":"180","author":"Krishnamoorthy","year":"2012","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0630","series-title":"Robbins and Cotran pathologic basis of disease, professional edition e-book","author":"Kumar","year":"2014"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0635","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41586-020-2941-1","article-title":"Decoding myofibroblast origins in human kidney fibrosis","volume":"589","author":"Kuppe","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0640","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/0005-2760(87)90118-4","article-title":"Transformation of 15-hydroperoxyeicosapentaenoic acid to lipoxin A5 and B5, mono- and dihydroxyeicosapentaenoic acids by porcine leukocytes","volume":"917","author":"Lam","year":"1987","journal-title":"Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0645","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.4049\/jimmunol.0903347","article-title":"Expression and function of CD300 in NK cells","volume":"185","author":"Lankry","year":"2010","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0650","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.4049\/jimmunol.1600859","article-title":"Resolvin E1 reverses experimental periodontitis and Dysbiosis","volume":"197","author":"Lee","year":"2016","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0655","doi-asserted-by":"crossref","first-page":"12111","DOI":"10.7150\/thno.52135","article-title":"Resolvin D3 controls mouse and human TRPV1-positive neurons and preclinical progression of psoriasis","volume":"10","author":"Lee","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0660","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1021\/nn301215q","article-title":"Targeted chemo-photothermal treatments of rheumatoid arthritis using gold half-shell multifunctional nanoparticles","volume":"7","author":"Lee","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0665","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.jaci.2022.01.030","article-title":"Selected recent advances in understanding the role of human mast cells in health and disease","volume":"149","author":"Levi-Schaffer","year":"2022","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0670","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.it.2017.10.001","article-title":"Inhibitory and Coactivating receptors Recognising the same ligand: Immune homeostasis exploited by pathogens and Tumours","volume":"39","author":"Levi-Schaffer","year":"2018","journal-title":"Trends in Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0675","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1002\/eji.1830201213","article-title":"Effects of prolonged incubation of rat peritoneal mast cells with compound 48\/80","volume":"20","author":"Levi-Schaffer","year":"1990","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0680","doi-asserted-by":"crossref","first-page":"5554","DOI":"10.4049\/jimmunol.160.11.5554","article-title":"Mast cells enhance eosinophil survival in vitro: Role of TNF-alpha and granulocyte-macrophage colony-stimulating factor","volume":"160","author":"Levi-Schaffer","year":"1998","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0685","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jaci.2019.09.028","article-title":"Cysteinyl maresins regulate the prophlogistic lung actions of cysteinyl leukotrienes","volume":"145","author":"Levy","year":"2020","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0690","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1164\/rccm.200410-1413OC","article-title":"Diminished Lipoxin biosynthesis in severe asthma","volume":"172","author":"Levy","year":"2005","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0695","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/89759","article-title":"Lipid mediator class switching during acute inflammation: Signals in resolution","volume":"2","author":"Levy","year":"2001","journal-title":"Nature Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0700","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/nm748","article-title":"Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4","volume":"8","author":"Levy","year":"2002","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0705","doi-asserted-by":"crossref","first-page":"496","DOI":"10.4049\/jimmunol.178.1.496","article-title":"Protectin D1 is generated in asthma and dampens airway inflammation and Hyperresponsiveness1","volume":"178","author":"Levy","year":"2007","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0710","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1172\/JCI116738","article-title":"Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins","volume":"92","author":"Levy","year":"1993","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0715","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1146\/annurev-physiol-021113-170408","article-title":"Resolution of acute inflammation in the lung","volume":"76","author":"Levy","year":"2014","journal-title":"Annual Review of Physiology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0720","article-title":"Resolvin D1 prevents injurious neutrophil swarming in transplanted lungs","volume":"120","author":"Li","year":"2023","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0725","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3760\/cma.j.issn.0366-6999.20131104","article-title":"Protectin D1 promotes resolution of inflammation in a murine model of lipopolysaccharide-induced acute lung injury via enhancing neutrophil apoptosis","volume":"127","author":"Li","year":"2014","journal-title":"Chinese Medical Journal"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0730","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.immuni.2013.10.011","article-title":"Plasticity of Leukocytic exudates in resolving acute inflammation is regulated by MicroRNA and proresolving mediators","volume":"39","author":"Li","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0735","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.631319","article-title":"A new E-series Resolvin: RvE4 stereochemistry and function in Efferocytosis of inflammation-resolution","volume":"11","author":"Libreros","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109660","article-title":"Lipoxin A4 inhibits ovalbumin-induced airway inflammation and airway remodeling in a mouse model of asthma","volume":"349","author":"Liu","year":"2021","journal-title":"Chemico-Biological Interactions"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.crneur.2023.100093","article-title":"Maresin-2 inhibits inflammatory and neuropathic trigeminal pain and reduces neuronal activation in the trigeminal ganglion","volume":"4","author":"Lopes","year":"2023","journal-title":"Current Research in Neurobiology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0750","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00745","article-title":"Resolvin D5 inhibits neuropathic and inflammatory pain in male but not female mice: Distinct actions of D-series Resolvins in chemotherapy-induced peripheral neuropathy","volume":"10","author":"Luo","year":"2019","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0755","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1021\/acsptsci.2c00042","article-title":"Molecular Mechanisms of Desensitization Underlying the Differential Effects of Formyl Peptide Receptor 2 Agonists on Cardiac Structure\u2013Function Post Myocardial Infarction","volume":"5","author":"Lupisella","year":"2022","journal-title":"ACS Pharmacology & Translational Science"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101602","article-title":"Formyl peptide receptor 2 and heart disease","volume":"59","author":"Lupisella","year":"2022","journal-title":"Seminars in Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0765","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.1074\/jbc.272.11.6972","article-title":"Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked Lipoxin A4 receptor*","volume":"272","author":"Maddox","year":"1997","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0770","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1084\/jem.183.1.137","article-title":"Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: Selective inactivation by dehydrogenation and reduction","volume":"183","author":"Maddox","year":"1996","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0775","doi-asserted-by":"crossref","first-page":"43807","DOI":"10.1074\/jbc.M305841200","article-title":"Novel Docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression*","volume":"278","author":"Marcheselli","year":"2003","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0780","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.4049\/jimmunol.1202743","article-title":"Maresin 1, a Proresolving lipid mediator derived from Omega-3 polyunsaturated fatty acids, exerts protective actions in murine models of colitis","volume":"191","author":"Marcon","year":"2013","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0785","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13393","article-title":"Metabolipidomic profiling reveals an age-related deficiency of skeletal muscle pro-resolving mediators that contributes to maladaptive tissue remodeling","volume":"20","author":"Markworth","year":"2021","journal-title":"Aging Cell"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0790","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.3390\/ijms21041384","article-title":"The novel small-molecule Annexin-A1 mimetic, compound 17b, elicits Vasoprotective actions in Streptozotocin-induced diabetic mice","volume":"21","author":"Marshall","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0795","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1016\/S0022-3476(05)81247-8","article-title":"Tissue levels of polyunsaturated fatty acids during early human development","volume":"120","author":"Martinez","year":"1992","journal-title":"The Journal of Pediatrics"},{"issue":"6","key":"10.1016\/j.pharmthera.2024.108753_bb0800","first-page":"1918","article-title":"Epeleuton, a novel synthetic \u03c9-3 fatty acid, reduces the hypoxia\/reperfusion stress in a mouse model of sickle cell disease","volume":"109","author":"Matt\u00e8","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0805","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-019-0069-0","article-title":"Acute respiratory distress syndrome","volume":"5","author":"Matthay","year":"2019","journal-title":"Nature Reviews Disease Primers"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0810","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhitov","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0815","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMra1413456","article-title":"Viral bronchiolitis in children","volume":"374","author":"Meissner","year":"2016","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105292","article-title":"Relevance of angiotensin-(1-7) and its receptor mas in pneumonia caused by influenza virus and post-influenza pneumococcal infection","volume":"163","author":"Melo","year":"2021","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0825","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1093\/eurheartj\/ehad269","article-title":"Diet, cardiovascular disease, and mortality in 80 countries","volume":"44","author":"Mente","year":"2023","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0830","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1007\/BF02544068","article-title":"Guinea pig epidermis generates putative anti-inflammatory metabolites from fish oil polyunsaturated fatty acids","volume":"24","author":"Miller","year":"1989","journal-title":"Lipids"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0835","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00011-009-0042-6","article-title":"Mast cells and eosinophils: The two key effector cells in allergic inflammation","volume":"58","author":"Minai-Fleminger","year":"2009","journal-title":"Inflammation Research"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0840","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1097\/01.ASN.0000032417.73640.72","article-title":"Lipoxins, Aspirin-Triggered Epi-Lipoxins, Lipoxin Stable Analogues, and the Resolution of Inflammation: Stimulation of macrophage phagocytosis of apoptotic neutrophils: In Vivo","volume":"13","author":"Mitchell","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101603","article-title":"Translational advances of melanocortin drugs: Integrating biology, chemistry and genetics","volume":"59","author":"Montero-Melendez","year":"2022","journal-title":"Seminars in Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0850","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.4049\/jimmunol.1402645","article-title":"Biased Agonism as a novel strategy to harness the Proresolving properties of Melanocortin receptors without eliciting melanogenic effects","volume":"194","author":"Montero-Melendez","year":"2015","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0855","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cell.2013.02.027","article-title":"The lipid mediator Protectin D1 inhibits influenza virus replication and improves severe influenza","volume":"153","author":"Morita","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0860","doi-asserted-by":"crossref","first-page":"8491","DOI":"10.1073\/pnas.0402531101","article-title":"Neuroprotectin D1: A docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress","volume":"101","author":"Mukherjee","year":"2004","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0865","doi-asserted-by":"crossref","first-page":"12152","DOI":"10.3390\/ijms241512152","article-title":"Melanocortin 1 receptor (MC1R): Pharmacological and therapeutic aspects","volume":"24","author":"Mun","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0870","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1084\/jem.20120096","article-title":"Apoptotic cells suppress mast cell inflammatory responses via the CD300a immunoreceptor","volume":"209","author":"Nakahashi-Oda","year":"2012","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0875","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41431-023-01462-1","article-title":"A comprehensive SARS-CoV-2 and COVID-19 review, Part 2: Host extracellular to systemic effects of SARS-CoV-2 infection","volume":"32","author":"Narayanan","year":"2024","journal-title":"European Journal of Human Genetics"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0880","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.4049\/jimmunol.1003865","article-title":"Cutting edge: Humanized Nano-Proresolving medicines mimic inflammation-resolution and enhance wound healing","volume":"186","author":"Norling","year":"2011","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0885","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax4895","article-title":"Resolution metabolomes activated by hypoxic environment","volume":"5","author":"Norris","year":"2019","journal-title":"Science Advances"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0890","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115203","article-title":"Resolvin D3 improves the impairment of insulin signaling in skeletal muscle and nonalcoholic fatty liver disease through AMPK\/autophagy-associated attenuation of ER stress","volume":"203","author":"Oh","year":"2022","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0895","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1172\/JCI42545","article-title":"Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation","volume":"121","author":"Oh","year":"2011","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0900","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1182\/blood-2014-03-562876","article-title":"Aspirin-triggered 15-epi-lipoxin A4 regulates neutrophil-platelet aggregation and attenuates acute lung injury in mice","volume":"124","author":"Ortiz-Mu\u00f1oz","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0905","doi-asserted-by":"crossref","first-page":"15072","DOI":"10.1523\/JNEUROSCI.2443-11.2011","article-title":"Resolving TRPV1- and TNF-\u03b1-mediated spinal cord synaptic plasticity and inflammatory pain with Neuroprotectin D1","volume":"31","author":"Park","year":"2011","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0910","doi-asserted-by":"crossref","first-page":"18433","DOI":"10.1523\/JNEUROSCI.4192-11.2011","article-title":"Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1\/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: Distinct roles of Resolvin D1, D2, and E1","volume":"31","author":"Park","year":"2011","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0915","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1182\/blood-2006-08-038844","article-title":"The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues","volume":"109","author":"Parolini","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0920","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(17)30129-0","article-title":"Influenza","volume":"390","author":"Paules","year":"2017","journal-title":"The Lancet"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0925","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/all.15920","article-title":"Resolvin D2 regulates type 2 inflammatory responses and promotes resolution of mouse allergic inflammation","volume":"79","author":"Peh","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0930","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202400610R","article-title":"15-epi-lipoxin A promotes neutrophil exit from exudates for clearance by splenic macrophages","volume":"38","author":"Peh","year":"2024","journal-title":"The FASEB Journal"},{"issue":"22","key":"10.1016\/j.pharmthera.2024.108753_bb0935","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1111\/bph.17310","article-title":"Biased receptor signalling and intracellular trafficking profiles of structurally distinct formylpeptide receptor 2 agonists","volume":"181","author":"Peng","year":"2024","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0940","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100073R","article-title":"Fish oil replacement prevents, while docosahexaenoic acid-derived protectin DX mitigates end-stage-renal-disease in atherosclerotic diabetic mice","volume":"35","author":"Perazza","year":"2021","journal-title":"FASEB Journal"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0945","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/nm786","article-title":"Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor","volume":"8","author":"Perretti","year":"2002","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0950","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1146\/annurev-pharmtox-051821-042743","article-title":"Resolution pharmacology: Focus on pro-resolving Annexin A1 and lipid mediators for therapeutic innovation in inflammation","volume":"63","author":"Perretti","year":"2023","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0955","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175786","article-title":"Characterizing the anti-inflammatory and tissue protective actions of a novel Annexin A1 peptide","volume":"12","author":"Perretti","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0960","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1111\/bph.15212","article-title":"Formyl peptide receptor type 2 agonists to kick-start resolution pharmacology","volume":"177","author":"Perretti","year":"2020","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0965","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-61390-8","article-title":"Novel RvD6 stereoisomer induces corneal nerve regeneration and wound healing post-injury by modulating trigeminal transcriptomic signature","volume":"10","author":"Pham","year":"2020","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0970","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1067\/mai.2000.105122","article-title":"15-lipoxygenase expression and 15(S)-hydroxyeicoisatetraenoic acid release and reincorporation in induced sputum of asthmatic subjects","volume":"105","author":"Profita","year":"2000","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0975","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00571","article-title":"Identification of AnnexinA1 as an endogenous regulator of RhoA, and its role in the pathophysiology and experimental therapy of Type-2 diabetes","volume":"10","author":"Purvis","year":"2019","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0980","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1159\/000529606","article-title":"CD300a regulates mouse macrophage functionality in allergic inflammation","volume":"184","author":"Puzzovio","year":"2023","journal-title":"International Archives of Allergy and Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0985","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106691","article-title":"Mast cells contribute to the resolution of allergic inflammation by releasing resolvin D1","volume":"189","author":"Puzzovio","year":"2023","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0990","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1476-5381.2012.02176.x","article-title":"Reperfusion-induced myocardial dysfunction is prevented by endogenous annexin-A1 and its N-terminal-derived peptide ac-ANX-A12-26","volume":"168","author":"Qin","year":"2013","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb0995","doi-asserted-by":"crossref","first-page":"14232","DOI":"10.1038\/ncomms14232","article-title":"Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice","volume":"8","author":"Qin","year":"2017","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1000","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1111\/bph.15919","article-title":"Formylpeptide receptor 2: Nomenclature, structure, signalling and translational perspectives: IUPHAR review 35","volume":"179","author":"Qin","year":"2022","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1005","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.plefa.2008.09.022","article-title":"Neuroprotectin D1 inhibits retinal ganglion cell death following axotomy","volume":"79","author":"Qin","year":"2008","journal-title":"Prostaglandins, Leukotrienes, and Essential Fatty Acids"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1010","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.ajpath.2015.12.012","article-title":"The Protectin PCTR1 is produced by human M2 macrophages and enhances resolution of infectious inflammation","volume":"186","author":"Ramon","year":"2016","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1015","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/MOL.0b013e32830d5f09","article-title":"Emigration of monocyte-derived cells to lymph nodes during resolution of inflammation and its failure in atherosclerosis","volume":"19","author":"Randolph","year":"2008","journal-title":"Current Opinion in Lipidology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1020","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neuropharm.2013.03.025","article-title":"Anti-inflammatory effects of angiotensin-(1-7) in ischemic stroke","volume":"71","author":"Regenhardt","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182381","article-title":"Lipoxin A4 encapsulated in PLGA microparticles accelerates wound healing of skin ulcers","volume":"12","author":"Reis","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1030","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/molehr\/gau117","article-title":"15-epi-lipoxin A4 reduces the mortality of prematurely born pups in a mouse model of infection-induced preterm birth","volume":"21","author":"Rinaldi","year":"2015","journal-title":"Molecular Human Reproduction"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1035","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1016\/j.tetlet.2005.03.175","article-title":"First total synthesis of 7(S),17(S)-Resolvin D5, a potent anti-inflammatory docosanoid","volume":"46","author":"Rodr\u00edguez","year":"2005","journal-title":"Tetrahedron Letters"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1040","doi-asserted-by":"crossref","first-page":"5811","DOI":"10.1016\/j.tetlet.2015.09.020","article-title":"Total synthesis of pro-resolving and tissue-regenerative Protectin sulfido-conjugates","volume":"56","author":"Rodriguez","year":"2015","journal-title":"Tetrahedron Letters"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1045","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.ajpath.2018.01.004","article-title":"Identification and complete Stereochemical assignments of the new Resolvin conjugates in tissue regeneration in human tissues that stimulate Proresolving phagocyte functions and tissue regeneration","volume":"188","author":"de la Rosa","year":"2018","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1050","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/(SICI)1521-4141(199805)28:05<1689::AID-IMMU1689>3.0.CO;2-I","article-title":"ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains","volume":"28","author":"Samson","year":"1998","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1055","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1126\/science.2820055","article-title":"Leukotrienes and Lipoxins: Structures, biosynthesis, and biological effects","volume":"237","author":"Samuelsson","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1060","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1034\/j.1399-3003.2000.16a08.x","article-title":"Aspirin-tolerant asthmatics generate more lipoxins than aspirin- intolerant asthmatics","volume":"16","author":"Sanak","year":"2000","journal-title":"European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1065","doi-asserted-by":"crossref","first-page":"14354","DOI":"10.1073\/pnas.1918163117","article-title":"Myeloid ALX\/FPR2 regulates vascularization following tissue injury","volume":"117","author":"Sansbury","year":"2020","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1070","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/jbm.a.36796","article-title":"Effects of treatment with gold nanoparticles in a model of acute pulmonary inflammation induced by lipopolysaccharide","volume":"108","author":"dos Santos Haupenthal","year":"2020","journal-title":"Journal of Biomedical Materials Research Part A"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1075","doi-asserted-by":"crossref","first-page":"12750","DOI":"10.1096\/fj.201900283R","article-title":"Resolvin E3 attenuates allergic airway inflammation via the interleukin-23-interleukin-17A pathway","volume":"33","author":"Sato","year":"2019","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1080","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1084\/jem.20150381","article-title":"Resolvin E1 inhibits dendritic cell migration in the skin and attenuates contact hypersensitivity responses","volume":"212","author":"Sawada","year":"2015","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1085","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/bph.16261","article-title":"Meloxicam treatment disrupts the regional structure of innate inflammation sites by targeting the pro-inflammatory effects of prostanoids","volume":"181","author":"Sch\u00e4ufele","year":"2024","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2017.08.002","article-title":"New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration","volume":"64","author":"Serhan","year":"2018","journal-title":"Molecular Aspects of Medicine"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1095","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1100","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1096\/fj.201601222R","article-title":"Treating inflammation and infection in the 21st century: New hints from decoding resolution mediators and mechanisms","volume":"31","author":"Serhan","year":"2017","journal-title":"FASEB Journal\u202f: Official Publication of the Federation of American Societies for Experimental Biology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1105","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2023.106718","article-title":"Resolvins and cysteinyl-containing pro-resolving mediators activate resolution of infectious inflammation and tissue regeneration","volume":"166","author":"Serhan","year":"2023","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1110","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nri2294","article-title":"Resolving inflammation: Dual anti-inflammatory and pro-resolution lipid mediators","volume":"8","author":"Serhan","year":"2008","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1115","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1084\/jem.192.8.1197","article-title":"Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing","volume":"192","author":"Serhan","year":"2000","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1120","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1096\/fj.11-201442","article-title":"Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain","volume":"26","author":"Serhan","year":"2012","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1125","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.4049\/jimmunol.176.3.1848","article-title":"Anti-inflammatory actions of Neuroprotectin D1\/Protectin D1 and its natural stereoisomers: Assignments of Dihydroxy-containing Docosatrienes1","volume":"176","author":"Serhan","year":"2006","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1130","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1073\/pnas.81.17.5335","article-title":"Lipoxins: Novel series of biologically active compounds formed from arachidonic acid in human leukocytes","volume":"81","author":"Serhan","year":"1984","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1135","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0006-291X(84)91486-4","article-title":"Trihydroxytetraenes: A novel series of compounds formed from arachidonic acid in human leukocytes","volume":"118","author":"Serhan","year":"1984","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1140","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.20020760","article-title":"Resolvins\u202f: A family of bioactive products of Omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter Proinflammation signals","volume":"196","author":"Serhan","year":"2002","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1145","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1172\/JCI97943","article-title":"Resolvins in inflammation: Emergence of the pro-resolving superfamily of mediators","volume":"128","author":"Serhan","year":"2018","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1150","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101597","article-title":"E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition","volume":"59","author":"Serhan","year":"2022","journal-title":"Seminars in Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1155","doi-asserted-by":"crossref","first-page":"14609","DOI":"10.1021\/bi00044a041","article-title":"Design of Lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils","volume":"34","author":"Serhan","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1160","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ni1276","article-title":"Resolution of inflammation: The beginning programs the end","volume":"6","author":"Serhan","year":"2005","journal-title":"Nature Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1165","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1172\/JCI114503","article-title":"Lipoxin formation during human neutrophil-platelet interactions: Evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitro","volume":"85","author":"Serhan","year":"1990","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1170","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1084\/jem.20081880","article-title":"Maresins: Novel macrophage mediators with potent antiinflammatory and proresolving actions","volume":"206","author":"Serhan","year":"2008","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1175","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.chembiol.2011.06.008","article-title":"Novel Proresolving aspirin-triggered DHA pathway","volume":"18","author":"Serhan","year":"2011","journal-title":"Chemistry & Biology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1180","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.3390\/antiox11091659","article-title":"Gold nanoparticles inhibit steroid-insensitive asthma in mice preserving histone deacetylase 2 and NRF2 pathways","volume":"11","author":"Serra","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1185","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.4049\/jimmunol.1602090","article-title":"15-epi-Lipoxin A4, Resolvin D2, and Resolvin D3 induce NF-\u03baB regulators in bacterial pneumonia","volume":"200","author":"Sham","year":"2018","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1190","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1164\/ajrccm\/147.4.1024","article-title":"Histochemical evidence for induction of Arachidonate 15-lipoxygenase in airway disease","volume":"147","author":"Shannon","year":"1993","journal-title":"American Review of Respiratory Disease"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1195","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.4049\/jimmunol.1000314","article-title":"Anti-inflammatory effects of the activation of the angiotensin-(1\u20137) receptor, mas, in experimental models of arthritis","volume":"185","author":"da Silveira","year":"2010","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1200","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1182\/blood-2011-08-372425","article-title":"Human CD300a binds to phosphatidylethanolamine and phosphatidylserine, and modulates the phagocytosis of dead cells","volume":"119","author":"Simhadri","year":"2012","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.pharmthera.2024.108753_bb1205","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/cvr\/cvae103","article-title":"Novel formylpeptide receptor 1\/2 agonist limits hypertension-induced cardiovascular damage","volume":"120","author":"Singh","year":"2024","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1210","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301802R","article-title":"The pro-resolving mediator, annexin A1 regulates blood pressure, and age-associated changes in cardiovascular function and remodeling","volume":"38","author":"Singh","year":"2024","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1215","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.tips.2023.01.001","article-title":"Rethinking the use of NSAIDs in early acute pain","volume":"44","author":"Sisignano","year":"2023","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1220","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1225","doi-asserted-by":"crossref","first-page":"8533","DOI":"10.4049\/jimmunol.179.12.8533","article-title":"The required role of endogenously produced Lipoxin A4 and Annexin-1 for the production of IL-10 and inflammatory Hyporesponsiveness in Mice1","volume":"179","author":"Souza","year":"2007","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1230","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/nature08541","article-title":"Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis","volume":"461","author":"Spite","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1235","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/bcp.13149","article-title":"Biomarker-guided clinical development of the first-in-class anti-inflammatory FPR2\/ALX agonist ACT-389949","volume":"83","author":"Stalder","year":"2017","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1240","series-title":"NHIS Adult Summary Health Statistics","article-title":"Percentage of current asthma for adults aged 18 and over, United States, 2022","volume":"2024","author":"Statistics","year":"2023"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1245","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.it.2019.01.007","article-title":"Mediators of the resolution of the inflammatory response","volume":"40","author":"Sugimoto","year":"2019","journal-title":"Trends in Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1250","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s42255-022-00590-0","article-title":"Brown adipose tissue-derived MaR2 contributes to cold-induced resolution of inflammation","volume":"4","author":"Sugimoto","year":"2022","journal-title":"Nature Metabolism"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1255","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41598-018-36909-9","article-title":"Pro-resolving lipid mediator ameliorates obesity induced osteoarthritis by regulating synovial macrophage polarisation","volume":"9","author":"Sun","year":"2019","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1260","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2147\/JIR.S442729","article-title":"Maresin-1 attenuates Sepsis-associated acute kidney injury via suppressing inflammation, endoplasmic reticulum stress and Pyroptosis by activating the AMPK\/SIRT3 pathway","volume":"17","author":"Sun","year":"2024","journal-title":"Journal of Inflammation Research"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1265","doi-asserted-by":"crossref","first-page":"9323","DOI":"10.1074\/jbc.M609212200","article-title":"Resolvin D1 and its aspirin-triggered 17R Epimer: Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation*","volume":"282","author":"Sun","year":"2007","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1270","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1084\/jem.20061826","article-title":"Lipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processing","volume":"204","author":"Svensson","year":"2007","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1275","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/02770900701847068","article-title":"The role of Lipoxin A4 in exercise-induced bronchoconstriction in asthma","volume":"45","author":"Tahan","year":"2008","journal-title":"Journal of Asthma"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1280","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1172\/JCI1578","article-title":"Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues","volume":"101","author":"Takano","year":"1998","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1285","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.185.9.1693","article-title":"Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: Evidence for anti-inflammatory receptors","volume":"185","author":"Takano","year":"1997","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1290","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cell.2013.05.052","article-title":"Lipidomic profiling of influenza infection identifies mediators that induce and resolve inflammation","volume":"154","author":"Tam","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1295","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1038\/srep05412","article-title":"PPAR\u03b2\/\u03b4 activation of CD300a controls intestinal immunity","volume":"4","author":"Tanaka","year":"2014","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1300","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11249-y","article-title":"Neutrophils-related host factors associated with severe disease and fatality in patients with influenza infection","volume":"10","author":"Tang","year":"2019","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1305","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.687046","article-title":"Spinal cord stimulation attenuates mechanical allodynia and increases central Resolvin D1 levels in rats with spared nerve injury","volume":"12","author":"Tao","year":"2021","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1310","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01267-22","article-title":"Cysteinyl Maresins reprogram macrophages to protect mice from Streptococcus pneumoniae after influenza A virus infection","volume":"13","author":"Tavares","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1315","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104881","article-title":"Granulocyte-targeted therapies for airway diseases","volume":"157","author":"Tavares","year":"2020","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1320","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00395-016-0583-0","article-title":"The spleen contributes importantly to myocardial infarct exacerbation during post-ischemic reperfusion in mice via signaling between cardiac HMGB1 and splenic RAGE","volume":"111","author":"Tian","year":"2016","journal-title":"Basic Research in Cardiology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1325","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.chembiol.2006.09.011","article-title":"Resolvin E2: Identification and anti-inflammatory actions: Pivotal role of human 5-lipoxygenase in Resolvin E series biosynthesis","volume":"13","author":"Tjonahen","year":"2006","journal-title":"Chemistry & Biology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1330","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1021\/jm201416p","article-title":"Anti-inflammatory active gold(I) complexes involving 6-substituted-purine derivatives","volume":"55","author":"Tr\u00e1vn\u00ed\u010dek","year":"2012","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1335","article-title":"Pro-resolving lipid mediator lipoxin A<sub>4<\/sub> attenuates neuro-inflammation by modulating T&#xa0;cell responses and modifies the spinal cord lipidome","volume":"35","author":"Troletti","year":"2021","journal-title":"Cell Reports"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1340","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tem.2012.12.001","article-title":"Appetite and the brain: You are what you eat","volume":"24","author":"Tzameli","year":"2013","journal-title":"Trends in Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1345","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaci.2004.09.038","article-title":"Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound","volume":"115","author":"Vachier","year":"2005","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1350","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2303814120","article-title":"NLRP3 is essential for neutrophil polarization and chemotaxis in response to leukotriene B4 gradient","volume":"120","author":"Van Bruggen","year":"2023","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1355","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1378\/chest.129.6.1673","article-title":"Burying the dead: The impact of failed apoptotic cell removal (Efferocytosis) on chronic inflammatory lung disease","volume":"129","author":"Vandivier","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1360","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990&#x2013;2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"The Lancet"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1365","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.704427","article-title":"Protectins PCTR1 and PD1 reduce viral load and lung inflammation during respiratory syncytial virus infection in mice","volume":"12","author":"Walker","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1370","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0140-6736(24)00138-7","article-title":"Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: A systematic review and meta-analysis of aggregated and individual participant data","volume":"403","author":"Wang","year":"2024","journal-title":"The Lancet"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1375","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nm.3549","article-title":"Protectin DX alleviates insulin resistance by activating a myokine-liver glucoregulatory axis","volume":"20","author":"White","year":"2014","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1380","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/JLB.3MI0617-254R","article-title":"Frontline science: Structural insights into Resolvin D4 actions and further metabolites via a new total organic synthesis and validation","volume":"103","author":"Winkler","year":"2018","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1385","doi-asserted-by":"crossref","first-page":"18972","DOI":"10.1038\/srep18972","article-title":"Resolvin D4 stereoassignment and its novel actions in host protection and bacterial clearance","volume":"6","author":"Winkler","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1390","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1021\/ol400484u","article-title":"Stereocontrolled Total synthesis of the potent anti-inflammatory and pro-resolving lipid mediator Resolvin D3 and its aspirin-triggered 17R-Epimer","volume":"15","author":"Winkler","year":"2013","journal-title":"Organic Letters"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1395","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1084\/jem.20030382","article-title":"Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids","volume":"198","author":"Wittamer","year":"2003","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1400","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2133.2012.11177.x","article-title":"Efficacy and safety of 15(R\/S)-methyl-lipoxin A4 in topical treatment of infantile eczema","volume":"168","author":"Wu","year":"2013","journal-title":"British Journal of Dermatology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1405","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6254587","article-title":"Resolvin D1 alleviates ventilator-induced lung injury in mice by activating PPAR\u03b3\/NF-\u03baB signaling pathway","volume":"2019","author":"Xia","year":"2019","journal-title":"BioMed Research International"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1410","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11481-012-9394-8","article-title":"Resolvin E1 inhibits neuropathic pain and spinal cord microglial activation following peripheral nerve injury","volume":"8","author":"Xu","year":"2013","journal-title":"Journal of Neuroimmune Pharmacology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1415","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nm.2123","article-title":"Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions","volume":"16","author":"Xu","year":"2010","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1420","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96530-1","article-title":"Effect of resolvin D5 on T cell differentiation and osteoclastogenesis analyzed by lipid mediator profiling in the experimental arthritis","volume":"11","author":"Yamada","year":"2021","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1425","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1096\/fj.10-170027","article-title":"Eosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice","volume":"25","author":"Yamada","year":"2011","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1430","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-020-00243-2","article-title":"COVID-19: Immunopathogenesis and Immunotherapeutics","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1435","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.bja.2018.10.062","article-title":"Maresin 1 attenuates neuroinflammation in a mouse model of perioperative neurocognitive disorders","volume":"122","author":"Yang","year":"2019","journal-title":"British Journal of Anaesthesia"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1440","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1442-200x.2005.02039.x","article-title":"Neutrophil-mediated inflammation in respiratory syncytial viral bronchiolitis","volume":"47","author":"Yasui","year":"2005","journal-title":"Pediatrics International"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1445","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1124\/pr.109.001578","article-title":"International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family","volume":"61","author":"Ye","year":"2009","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1450","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.4049\/jimmunol.181.5.3515","article-title":"Phosphorylation of 5-lipoxygenase at Ser523 by protein kinase A determines whether pioglitazone and atorvastatin induce Proinflammatory leukotriene B4 or anti-inflammatory 15-epi-Lipoxin A4 production","volume":"181","author":"Ye","year":"2008","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1455","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.491","article-title":"Maresin-1 ameliorates hypertensive vascular remodeling through its receptor LGR6","volume":"5","author":"Yin","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1460","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.147819","article-title":"Angiotensin-(1-7)\/MasR axis promotes migration of monocytes\/macrophages with a regulatory phenotype to perform phagocytosis and efferocytosis","volume":"7","author":"Zaidan","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1465","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40169-017-0153-6","article-title":"Significance of long chain polyunsaturated fatty acids in human health","volume":"6","author":"Z\u00e1rate","year":"2017","journal-title":"Clinical and Translational Medicine"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1470","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.4049\/jimmunol.1500304","article-title":"The biology and disease relevance of CD300a, an inhibitory receptor for phosphatidylserine and phosphatidylethanolamine","volume":"194","author":"Zenarruzabeitia","year":"2015","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1475","article-title":"Distinct analgesic actions of DHA and DHA-derived specialized pro-resolving mediators on post-operative pain after bone fracture in mice","volume":"9","author":"Zhang","year":"2018","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1480","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1161\/CIRCULATIONAHA.116.021894","article-title":"Resolvin D2 enhances Postischemic revascularization while resolving inflammation","volume":"134","author":"Zhang","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1485","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.yexcr.2018.07.016","article-title":"FPR1 gene silencing suppresses cardiomyocyte apoptosis and ventricular remodeling in rats with ischemia\/reperfusion injury through the inhibition of MAPK signaling pathway","volume":"370","author":"Zhou","year":"2018","journal-title":"Experimental Cell Research"},{"key":"10.1016\/j.pharmthera.2024.108753_bb1490","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3390\/cells10020381","article-title":"Angiotensin II and angiotensin receptors 1 and 2\u2014Multifunctional system in cells biology, what Do we know?","volume":"10","author":"Ziaja","year":"2021","journal-title":"Cells"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725824001736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725824001736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T09:29:25Z","timestamp":1733909365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725824001736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":298,"alternative-id":["S0163725824001736"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2024.108753","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pro-resolving lipid mediators and therapeutic innovations in resolution of inflammation","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2024.108753","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108753"}}